Legal & General Group
TLSI icon

Legal & General Group’s TriSalus Life Sciences TLSI Stock Holding History

Legal & General Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Sell
2,733
-137
-5% -$671 ﹤0.01% 3159
2025
Q4 		$20K Buy
2,870
+1,416
+97% +$7.93K ﹤0.01% 3030
2025
Q3 		$6.76K Hold
1,454
– – ﹤0.01% 3344
2025
Q2 		$7.92K Buy
+1,454
New +$7.8K ﹤0.01% 3341

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Legal & General Group's TLSI Position: Q1 2026 in Review

Legal & General Group reduced its TriSalus Life Sciences (TLSI) stake by 4.8% in Q1 2026, selling an estimated $671 and leaving 2,733 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3159.

Legal & General Group first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. The position peaked at $20K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Legal & General Group held 2,733 shares of TriSalus Life Sciences worth $10.9K as of Q1 2026.
  • Legal & General Group sold 137 TriSalus Life Sciences shares in Q1 2026, an estimated $671.
  • TriSalus Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3159 holding.
  • Legal & General Group first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Legal & General Group's TriSalus Life Sciences position peaked at $20K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.